Geode Capital Management LLC Buys 93,253 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Geode Capital Management LLC raised its position in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 7.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,391,718 shares of the company’s stock after purchasing an additional 93,253 shares during the period. Geode Capital Management LLC owned 1.64% of Stereotaxis worth $2,840,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of the company. SG Americas Securities LLC purchased a new stake in shares of Stereotaxis during the 3rd quarter valued at approximately $39,000. Jane Street Group LLC lifted its position in shares of Stereotaxis by 26.9% during the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock worth $61,000 after acquiring an additional 6,313 shares in the last quarter. Rhumbline Advisers lifted its position in shares of Stereotaxis by 645.6% during the second quarter. Rhumbline Advisers now owns 48,251 shares of the company’s stock worth $88,000 after acquiring an additional 41,780 shares in the last quarter. Barclays PLC boosted its stake in Stereotaxis by 449.9% in the 3rd quarter. Barclays PLC now owns 101,953 shares of the company’s stock worth $208,000 after purchasing an additional 83,412 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in Stereotaxis by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock valued at $341,000 after buying an additional 15,491 shares in the last quarter. 45.35% of the stock is owned by hedge funds and other institutional investors.

Stereotaxis Stock Performance

Shares of NYSEAMERICAN STXS opened at $2.39 on Wednesday. Stereotaxis, Inc. has a twelve month low of $1.66 and a twelve month high of $3.29. The stock has a market capitalization of $202.50 million, a price-to-earnings ratio of -8.54 and a beta of 1.57.

Stereotaxis (NYSEAMERICAN:STXS) last posted its quarterly earnings data on Monday, November 11th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). The firm had revenue of $9.20 million during the quarter, compared to analysts’ expectations of $6.80 million. Stereotaxis had a negative return on equity of 162.54% and a negative net margin of 85.79%. Research analysts forecast that Stereotaxis, Inc. will post -0.26 EPS for the current fiscal year.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.